Items where Division is "Current Faculties > Faculty of Medicine > Cancer Sciences > Immunology > Antibody and Vaccine Group
Cancer Sciences > Immunology > Antibody and Vaccine Group" and Year is 2023
 | Up a level |
Number of items: 30.
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease - Eleanor Barnes, Carl S. Goodyear and Michelle Willicombe
Type: Article
| 2023
Could anionic LDL be a ligand for RAGE and TREM2 in addition to LOX-1 and thus exacerbate lung disease and dementia? - Charles N. Birts and David C. Wilton
Type: Article
| 2023
The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer - Rhianna Rachael Romany Blyth, Charlie N. Birts and Stephen A. Beers
Type: Review
| 2023
A single bout of exercise enhances the efficacy of rituximab against autologous chronic lymphocytic leukaemia B cells ex vivo by transiently increasing natural killer cell frequency in blood, and simultaneously mobilises CD5 +CD19 +CD20 + B cells into blood - Harrison D. Collier-Bain, Annabelle Emery and Adam J. Causer
Type: Meeting abstract
| 2023
| Item not available on this server.
Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc - Osman Dadas, Joel D. Allen, Sarah L. Buchan, Jinny H. Kim, H.T. Claude Chan, C. Ian Mockridge, Patrick J. Duriez, Anne Rogel, Max Crispin and Aymen Al-Shamkhani
Type: Article
| 2023
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives - Osman Dadas, Ayse Ertay and Mark S. Cragg
Type: Review
| 2023
Special Issue “Advances in Genome Regulation in Cancer” - Jekaterina Erenpreisa, Alessandro Giuliani and Mark Steven Cragg
Type: Editorial
| 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression - Jack G. Fisher, Amber D.P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W.M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim I. Khakoo and Matthew D. Blunt
Type: Article
| 2023
Review: Targeting EZH2 in neuroblastoma - Jinhui Gao, Claire Fosbrook, Jane Gibson, Timothy J. Underwood, Juliet C. Gray and Zoë S. Walters
Type: Review
| 2023
Optimising urinary catecholamine metabolite diagnostics for neuroblastoma - Juliet Gray, Yvette A.H. Matser, Iedan R.N. Verly, Maria van der Ham, Monique G.M. de Sain-van der Velden, Nanda M. Verhoeven-Duif, Shifra Ash, Giuliana Cangemi, Sebastiano Barco, Maja Beck Popovic, Andre B.P. van Kuilenburg and Godelieve A.M. Tytgat
Type: Article
| 2023
The use of routinely collected electronic prescribing data to benchmark intravenous antibiotic use between two tertiary paediatric Haematology-Oncology inpatient units: a retrospective study - Caroline Herin, Samuel Channon-Wells, Ismail Elbeshlawi, Juliet Gray, Sanjay Patel and Stephane Paulus
Type: Article
| 2023
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity - Paul T. Kennedy, Emma L. Saulters, Andrew D. Duckworth, Yeong Jer Lim, John F. Woolley, Joseph R. Slupsky, Mark S. Cragg, Frank J. Ward and Lekh N. Dahal
Type: Article
| 2023
Regulation of human and mouse bystander T cell activation responses by PD-1 - Catherine T Le, Logan V Vick, Craig Collins, Cordelia Dunai, Michael K Sheng, Lam T Khuat, Isabel Barao, Sean J Judge, Ethan G Aguilar, Brendan Curti, Maneesh Dave, Dan L Longo, Bruce R Blazar, Robert J Canter, Arta M Monjazeb and William J Murphy
Type: Article
| 2023
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges - Sean H. Lim, Stephen A. Beers, Aymen Al-Shamkhani and Mark S. Cragg
Type: Article
| 2023
| Item availability restricted.
Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes - Alex Look, Daniel Burns and Ivo Tews
Type: Review
| 2023
Development of C1q affinity chromatography for the study of C1q-IgG interactions - Michael J.E. Marshall, Alexander Knaupp, Christian Spick, Ilker Koese, Maria Maier, Mark S. Cragg, Florian Cymer and Tilman Schlothauer
Type: Article
| 2023
Single-cell RNA-sequence analysis of human bone marrow reveals new targets for isolation of skeletal stem cells using spherical nucleic acids - Elloise Zena Matthews, Stuart Lanham, Kate Ward, Maria-Eleni Kyriazi, Konstantina Alexaki, Afaf El-Sagheer, Tom Brown, Antonios Kanaras, Jonathan West, Benjamin Macarthur, Patrick S Stumpf and Richard Oreffo
Type: Article
| 2023
Single cell RNA sequence analysis of human bone marrow samples reveals new targets for isolation of skeletal stem cells using DNA-coated gold nanoparticles - Elloise Zena Matthews, Stuart Lanham, Kate White, Maria-Eleni Kyriazi, Konstantina Alexaki, Afaf H. El-Sagheer, Tom Brown, Antonios Kanaras, Jonathan West, Benjamin Macarthur, Patrick S. Stumpf and Richard Oreffo
Type: Article
| 2023
Effect of posttranslational modifications and subclass on IgG activity: From Immunity to Immunotherapy - Falk Nimmerjahn, Gestur Vidarsson and Mark Cragg
Type: Article
| 2023
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY - Fiona A. Pearce, Sean H. Lim, Mary Bythell, Peter Lanyon, Rachel Hogg, Adam Taylor, Gillian Powter, Graham S. Cooke, Helen Ward, Joseph Chilcot, Helen Thomas, Lisa Mumford, Stephen P. McAdoo, Gavin J. Pettigrew, Liz Lightstone and Michelle Willicombe
Type: Article
| 2023
Human leukocyte immunoglobulin-like receptors in health and disease - Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, Muchaala Yeboah, Björn Frendeus, Mark S. Cragg and Ali Roghanian
Type: Review
| 2023
Obesity is associated with immunometabolic changes in adipose tissue that may drive treatment resistance in breast cancer: immune-metabolic reprogramming and novel therapeutic strategies - Constantinos Savva, Ellen Copson, Peter W.M. Johnson, Ramsey I. Cutress and Stephen A. Beers
Type: Review
| 2023
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma - Matt Sherwood, Yilu Zhou, Yi Sui, Yihua Wang, Paul Skipp, Carolini Kaid, Juliet Gray, Keith Okamoto and Rob Ewing
Type: Article
| 2023
Tri-lineage differentiation potential of osteosarcoma cell lines and human bone marrow stromal cells from different anatomical locations - Hannah L. Smith, Juliet C. Gray, Stephen A. Beers and Janos M. Kanczler
Type: Article
| 2023
Differences in coagulation-relevant parameters: comparing cryoprecipitate and a human fibrinogen concentrate - Sophia Stanford, Ashok Roy, Tom Cecil, Oliver Hegener, Petra Schulz, Anna Turaj, Sean Lim and Emily Arbuthnot
Type: Article
| 2023
Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the "obesity paradox" - Logan V Vick, Craig P Collins, Lam T Khuat, Ziming Wang, Cordelia Dunai, Ethan G Aguilar, Kevin Stoffel, Sai Yendamuri, Randall Smith, Sarbajit Mukherjee, Joseph Barbi, Robert J Canter, Arta M Monjazeb and William J Murphy
Type: Article
| 2023
| Item not available on this server.
Integrative analysis of neuroblastoma by single‐cell RNA sequencing identifies the NECTIN2‐TIGIT axis as a target for immunotherapy - Judith Wienke, Lindy L. Visser and Waleed M. Kholosy
Type: Article
| 2023
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing - Ratna Wijaya, Marina Johnson, Nicola Campbell, Beth Stuart, Adam Kelly, Nicole Tipler, Tobias Menne, Matthew J. Ahearne, Victoria Willimott, Anna Bowzyk Al-Naeeb, Christopher P. Fox, Graham P. Fox, Graham P. Collins, Ann O'Callaghan, Andrew J. Davies, David Goldblatt and Sean H. Lim
Type: Letter
| 2023
Type: Editorial
| 2023
| Item availability restricted.
Reducing affinity as a strategy to boost immunomodulatory antibody agonism - Xiaojie Yu, Christian Orr, H.T. Claude Chan, Sonya James, Christine A. Penfold, Jinny Kim, Tatyana Inzhelevskaya, C. Ian Mockridge, Kerry L. Cox, Jonathan W. Essex, Ivo Tews, Martin J. Glennie and Mark S. Cragg
Type: Article
| 2023